enGene Therapeutics Inc.

For the period ended Apr 30, 2026. Filed Jun 15, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Apr 30, 2026 · Filed Jun 15, 2026

ENGN$1.75+4.2%Stored close · as of Nov 6, 2026

Opening this filing…